Abreos Biosciences

Abreos Biosciences, founded in San Diego, is an early-stage biotechnology company focused on developing innovative laboratory-based and point-of-care assays. Their core mission is to enhance personalized medicine by enabling precise dosing and counterfeit detection of therapeutic monoclonal antibodies. Abreos Biosciences aims to serve the healthcare market in the United States, providing critical tools for clinicians to optimize treatment outcomes and ensure the authenticity of biologic therapies.

Notable figures affiliated with Abreos Biosciences include experts in biotechnology and healthcare innovation. The company has attracted investment from key players in the biotech sector, bolstering its research and development capabilities. Abreos Biosciences has achieved significant milestones in assay development, contributing to the broader field of personalized medicine. Their impact is evident in improved patient care through tailored therapeutic approaches and enhanced drug safety.